Abstract
A Saccharomyces cerevisiae N-myristoyltransferase (NMT) inhibitor bearing a tetrahydrocarbazole scaffold was found to possess broad-spectrum antifungal activity. A series of C6- and N9-modified tetrahydrocarbazole derivatives were designed and synthesized. An in vitro antifungal assay indicated that several tetrahydrocarbazole derivatives showed improved activity with a broad spectrum. Particularly, the inhibitory activity of compound 10c against Cryptococcus neoformans, Aspergillus fumigatus and M. gypseum was comparable or superior to that of fluconazole and benzofuran NMT inhibitors. The present study provides a good starting point for the discovery of novel antifungal agents.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
